Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.

1 report, 1 independent Updated Sep 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Goldman Sachs Interactive Brokers Vertex Pharmaceuticals

Keep exploring

Part of

Goldman Sachs, Evercore Partners, and Interactive Brokers compete in investment banking amid M&A market rebound, while Powell signals potential rate adjustments. All 1 developments

The entities involved

Goldman Sachs
American investment bank
- BXP purchased a building in Manhattan with Goldman Sachs, which is now occupied by Weil Gotshal.00:47
- Multiple financial institutions, including Goldman Sachs, Morgan Stanley, Bank of America, UBS, and others, provided ratings and price targets for Marvell Technology on May 28, 2026.Fri 22:25
Interactive Brokers
American multinational brokerage firm
- Interactive Brokers announced it is offering clients access to US markets, including Nasdaq.Thu 18:48
Vertex Pharmaceuticals
American pharmaceutical company
- CRISPR Therapeutics formed a strategic partnership with Vertex Pharmaceuticals.Sat 22:51

Related events

Barclays acquired a new stake in Interactive Brokers shares and raised its price target citing improving earnings prospects.Oct 18

Coverage

Newest first; wire copies grouped

Sep 2seekingalpha.com